Education
About Us
Working with TipRanks
Follow Us
Novo Nordisk (DE:NOV)
XETRA:NOV
Total Valuation
Novo Nordisk has a market cap or net worth of €184.77B. The enterprise value is €2.04T.
Market Cap€184.77B
Enterprise Value€2.04T
Share Statistics
Novo Nordisk has 3,390,128,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,390,128,000
Owned by Insiders0.04%
Owned by Institutions<0.01%
Financial Efficiency
Novo Nordisk’s return on equity (ROE) is 0.53 and return on invested capital (ROIC) is 31.23%.
Return on Equity (ROE)0.53
Return on Assets (ROA)0.19
Return on Invested Capital (ROIC)31.23%
Return on Capital Employed (ROCE)0.41
Revenue Per Employee3.99M
Profits Per Employee1.32M
Employee Count77,406
Asset Turnover0.57
Inventory Turnover1.22
Valuation Ratios
The current PE Ratio of Novo Nordisk is 13.5. Novo Nordisk’s PEG ratio is ―.
PE Ratio13.5
PS Ratio0.00
PB Ratio0.00
Price to Fair Value7.45
Price to FCF0.00
Price to Operating Cash Flow11.59
PEG Ratio―
Income Statement
In the last 12 months, Novo Nordisk had revenue of 309.06B and earned 102.43B in profits. Earnings per share was 23.06.
Revenue309.06B
Gross Profit248.31B
Operating Income135.02B
Pretax Income130.54B
Net Income102.43B
EBITDA149.44B
Earnings Per Share (EPS)23.06
Cash Flow
In the last 12 months, operating cash flow was 119.10B and capital expenditures -62.92B, giving a free cash flow of 56.18B billion.
Operating Cash Flow119.10B
Free Cash Flow56.18B
Free Cash Flow per Share16.57
Dividends & Yields
Novo Nordisk pays an annual dividend of €0.502, resulting in a dividend yield of 3.47%
Dividend Per Share€0.502
Dividend Yield3.47%
Payout Ratio49.93%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.99
52-Week Price Change-44.09%
50-Day Moving Average45.64
200-Day Moving Average49.90
Relative Strength Index (RSI)40.77
Average Volume (3m)333.55K
Important Dates
Novo Nordisk upcoming earnings date is May 6, 2026, Before Open (Confirmed).
Last Earnings DateFeb 3, 2026
Next Earnings DateMay 6, 2026
Ex-Dividend Date―
Financial Position
Novo Nordisk as a current ratio of 0.80, with Debt / Equity ratio of 67.49%
Current Ratio0.80
Quick Ratio0.57
Debt to Market Cap0.09
Net Debt to EBITDA0.70
Interest Coverage Ratio19.92
Taxes
In the past 12 months, Novo Nordisk has paid 28.11B in taxes.
Income Tax28.11B
Effective Tax Rate0.22
Enterprise Valuation
Novo Nordisk EV to EBITDA ratio is 10.37, with an EV/FCF ratio of 26.28.
EV to Sales5.01
EV to EBITDA10.37
EV to Free Cash Flow26.28
EV to Operating Cash Flow13.01
Balance Sheet
Novo Nordisk has €26.96B in cash and marketable securities with €118.72B in debt, giving a net cash position of -€104.00B billion.
Cash & Marketable Securities€26.96B
Total Debt€118.72B
Net Cash-€104.00B
Net Cash Per Share-€30.68
Tangible Book Value Per Share€14.40
Margins
Gross margin is 80.98%, with operating margin of 43.69%, and net profit margin of 33.14%.
Gross Margin80.98%
Operating Margin43.69%
Pretax Margin42.24%
Net Profit Margin33.14%
EBITDA Margin48.35%
EBIT Margin43.61%
Analyst Forecast
The average price target for Novo Nordisk is €46.99, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€46.99
Price Target Upside12.76% Upside
Analyst ConsensusModerate Buy
Analyst Count14
Revenue Growth Forecast―
EPS Growth Forecast―